COVID-19 Impact on Global Transdermal Skin Patch, Market Insights and Forecast to 2026
Transdermal Skin Patch market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Transdermal Skin Patch market is segmented into
The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transdermal Skin Patch Market Share Analysis
Transdermal Skin Patch market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Transdermal Skin Patch market is segmented into
- Fentanyl Transdermal Skin Patch
- Nicotine Transdermal Skin Patch
- Clonidine Transdermal Skin Patch
- Buprenorphine Transdermal Skin Patch
- Relieve Severe Pain
- Stop Smoking Cigarettes
- Treat An Overactive Bladder
- Others
The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transdermal Skin Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transdermal Skin Patch Market Share Analysis
Transdermal Skin Patch market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Skin Patch business, the date to enter into the Transdermal Skin Patch market, Transdermal Skin Patch product introduction, recent developments, etc.
The major vendors covered:
- Hisamitsu Pharmaceutical
- Novartis
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
- Luye Pharma Group Ltd.
- Purdue Pharma L.P.
- Teva Pharmaceutical Industries Ltd.
1 STUDY COVERAGE
1.1 Transdermal Skin Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
1.4.2 Fentanyl Transdermal Skin Patch
1.4.3 Nicotine Transdermal Skin Patch
1.4.4 Clonidine Transdermal Skin Patch
1.4.5 Buprenorphine Transdermal Skin Patch
1.5 Market by Application
1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
1.5.2 Relieve Severe Pain
1.5.3 Stop Smoking Cigarettes
1.5.4 Treat An Overactive Bladder
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Skin Patch Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal Skin Patch Industry
1.6.1.1 Transdermal Skin Patch Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal Skin Patch Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
2.1.2 Global Transdermal Skin Patch Sales 2015-2026
2.2 Transdermal Skin Patch Market Size by Region: 2020 Versus 2026
2.2.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TRANSDERMAL SKIN PATCH COMPETITOR LANDSCAPE BY PLAYERS
3.1 Transdermal Skin Patch Sales by Manufacturers
3.1.1 Transdermal Skin Patch Sales by Manufacturers (2015-2020)
3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Transdermal Skin Patch Revenue by Manufacturers
3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transdermal Skin Patch Price by Manufacturers
3.4 Transdermal Skin Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Skin Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Transdermal Skin Patch by Country
6.1.1 North America Transdermal Skin Patch Sales by Country
6.1.2 North America Transdermal Skin Patch Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transdermal Skin Patch Market Facts & Figures by Type
6.3 North America Transdermal Skin Patch Market Facts & Figures by Application
7 EUROPE
7.1 Europe Transdermal Skin Patch by Country
7.1.1 Europe Transdermal Skin Patch Sales by Country
7.1.2 Europe Transdermal Skin Patch Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Skin Patch Market Facts & Figures by Type
7.3 Europe Transdermal Skin Patch Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Transdermal Skin Patch by Region
8.1.1 Asia Pacific Transdermal Skin Patch Sales by Region
8.1.2 Asia Pacific Transdermal Skin Patch Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Type
8.3 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Transdermal Skin Patch by Country
9.1.1 Latin America Transdermal Skin Patch Sales by Country
9.1.2 Latin America Transdermal Skin Patch Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transdermal Skin Patch Market Facts & Figures by Type
9.3 Central & South America Transdermal Skin Patch Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Transdermal Skin Patch by Country
10.1.1 Middle East and Africa Transdermal Skin Patch Sales by Country
10.1.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Type
10.3 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Transdermal Skin Patch Products Offered
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Teikoku Pharma
11.4.1 Teikoku Pharma Corporation Information
11.4.2 Teikoku Pharma Description, Business Overview and Total Revenue
11.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
11.4.5 Teikoku Pharma Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Transdermal Skin Patch Products Offered
11.5.5 Mylan Recent Development
11.6 Actavis
11.6.1 Actavis Corporation Information
11.6.2 Actavis Description, Business Overview and Total Revenue
11.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Actavis Transdermal Skin Patch Products Offered
11.6.5 Actavis Recent Development
11.7 Mundipharma
11.7.1 Mundipharma Corporation Information
11.7.2 Mundipharma Description, Business Overview and Total Revenue
11.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mundipharma Transdermal Skin Patch Products Offered
11.7.5 Mundipharma Recent Development
11.8 Henan Lingrui Pharmaceutical
11.8.1 Henan Lingrui Pharmaceutical Corporation Information
11.8.2 Henan Lingrui Pharmaceutical Description, Business Overview and Total Revenue
11.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
11.8.5 Henan Lingrui Pharmaceutical Recent Development
11.9 Changzhou Siyao
11.9.1 Changzhou Siyao Corporation Information
11.9.2 Changzhou Siyao Description, Business Overview and Total Revenue
11.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
11.9.5 Changzhou Siyao Recent Development
11.10 Rfl Pharmaceutical
11.10.1 Rfl Pharmaceutical Corporation Information
11.10.2 Rfl Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
11.10.5 Rfl Pharmaceutical Recent Development
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.12 Purdue Pharma L.P.
11.12.1 Purdue Pharma L.P. Corporation Information
11.12.2 Purdue Pharma L.P. Description, Business Overview and Total Revenue
11.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Purdue Pharma L.P. Products Offered
11.12.5 Purdue Pharma L.P. Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.13.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview and Total Revenue
11.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Transdermal Skin Patch Market Estimates and Projections by Region
12.1.1 Global Transdermal Skin Patch Sales Forecast by Regions 2021-2026
12.1.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2021-2026
12.2 North America Transdermal Skin Patch Market Size Forecast (2021-2026)
12.2.1 North America: Transdermal Skin Patch Sales Forecast (2021-2026)
12.2.2 North America: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.2.3 North America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.3 Europe Transdermal Skin Patch Market Size Forecast (2021-2026)
12.3.1 Europe: Transdermal Skin Patch Sales Forecast (2021-2026)
12.3.2 Europe: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.3.3 Europe: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transdermal Skin Patch Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transdermal Skin Patch Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transdermal Skin Patch Market Size Forecast by Region (2021-2026)
12.5 Latin America Transdermal Skin Patch Market Size Forecast (2021-2026)
12.5.1 Latin America: Transdermal Skin Patch Sales Forecast (2021-2026)
12.5.2 Latin America: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.5.3 Latin America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transdermal Skin Patch Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transdermal Skin Patch Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Transdermal Skin Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Transdermal Skin Patch Product Introduction
1.2 Market Segments
1.3 Key Transdermal Skin Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transdermal Skin Patch Market Size Growth Rate by Type
1.4.2 Fentanyl Transdermal Skin Patch
1.4.3 Nicotine Transdermal Skin Patch
1.4.4 Clonidine Transdermal Skin Patch
1.4.5 Buprenorphine Transdermal Skin Patch
1.5 Market by Application
1.5.1 Global Transdermal Skin Patch Market Size Growth Rate by Application
1.5.2 Relieve Severe Pain
1.5.3 Stop Smoking Cigarettes
1.5.4 Treat An Overactive Bladder
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal Skin Patch Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal Skin Patch Industry
1.6.1.1 Transdermal Skin Patch Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal Skin Patch Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Skin Patch Revenue 2015-2026
2.1.2 Global Transdermal Skin Patch Sales 2015-2026
2.2 Transdermal Skin Patch Market Size by Region: 2020 Versus 2026
2.2.1 Global Transdermal Skin Patch Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transdermal Skin Patch Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TRANSDERMAL SKIN PATCH COMPETITOR LANDSCAPE BY PLAYERS
3.1 Transdermal Skin Patch Sales by Manufacturers
3.1.1 Transdermal Skin Patch Sales by Manufacturers (2015-2020)
3.1.2 Transdermal Skin Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Transdermal Skin Patch Revenue by Manufacturers
3.2.1 Transdermal Skin Patch Revenue by Manufacturers (2015-2020)
3.2.2 Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transdermal Skin Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transdermal Skin Patch Revenue in 2019
3.2.5 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transdermal Skin Patch Price by Manufacturers
3.4 Transdermal Skin Patch Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Skin Patch Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Skin Patch Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Skin Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Transdermal Skin Patch Market Size by Type (2015-2020)
4.1.1 Global Transdermal Skin Patch Sales by Type (2015-2020)
4.1.2 Global Transdermal Skin Patch Revenue by Type (2015-2020)
4.1.3 Transdermal Skin Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transdermal Skin Patch Market Size Forecast by Type (2021-2026)
4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2021-2026)
4.2.3 Transdermal Skin Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transdermal Skin Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Transdermal Skin Patch Market Size by Application (2015-2020)
5.1.1 Global Transdermal Skin Patch Sales by Application (2015-2020)
5.1.2 Global Transdermal Skin Patch Revenue by Application (2015-2020)
5.1.3 Transdermal Skin Patch Price by Application (2015-2020)
5.2 Transdermal Skin Patch Market Size Forecast by Application (2021-2026)
5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Transdermal Skin Patch by Country
6.1.1 North America Transdermal Skin Patch Sales by Country
6.1.2 North America Transdermal Skin Patch Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transdermal Skin Patch Market Facts & Figures by Type
6.3 North America Transdermal Skin Patch Market Facts & Figures by Application
7 EUROPE
7.1 Europe Transdermal Skin Patch by Country
7.1.1 Europe Transdermal Skin Patch Sales by Country
7.1.2 Europe Transdermal Skin Patch Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transdermal Skin Patch Market Facts & Figures by Type
7.3 Europe Transdermal Skin Patch Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Transdermal Skin Patch by Region
8.1.1 Asia Pacific Transdermal Skin Patch Sales by Region
8.1.2 Asia Pacific Transdermal Skin Patch Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Type
8.3 Asia Pacific Transdermal Skin Patch Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Transdermal Skin Patch by Country
9.1.1 Latin America Transdermal Skin Patch Sales by Country
9.1.2 Latin America Transdermal Skin Patch Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transdermal Skin Patch Market Facts & Figures by Type
9.3 Central & South America Transdermal Skin Patch Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Transdermal Skin Patch by Country
10.1.1 Middle East and Africa Transdermal Skin Patch Sales by Country
10.1.2 Middle East and Africa Transdermal Skin Patch Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Type
10.3 Middle East and Africa Transdermal Skin Patch Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description, Business Overview and Total Revenue
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Transdermal Skin Patch Products Offered
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
11.3.5 Johnson & Johnson Recent Development
11.4 Teikoku Pharma
11.4.1 Teikoku Pharma Corporation Information
11.4.2 Teikoku Pharma Description, Business Overview and Total Revenue
11.4.3 Teikoku Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
11.4.5 Teikoku Pharma Recent Development
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description, Business Overview and Total Revenue
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Transdermal Skin Patch Products Offered
11.5.5 Mylan Recent Development
11.6 Actavis
11.6.1 Actavis Corporation Information
11.6.2 Actavis Description, Business Overview and Total Revenue
11.6.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Actavis Transdermal Skin Patch Products Offered
11.6.5 Actavis Recent Development
11.7 Mundipharma
11.7.1 Mundipharma Corporation Information
11.7.2 Mundipharma Description, Business Overview and Total Revenue
11.7.3 Mundipharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Mundipharma Transdermal Skin Patch Products Offered
11.7.5 Mundipharma Recent Development
11.8 Henan Lingrui Pharmaceutical
11.8.1 Henan Lingrui Pharmaceutical Corporation Information
11.8.2 Henan Lingrui Pharmaceutical Description, Business Overview and Total Revenue
11.8.3 Henan Lingrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
11.8.5 Henan Lingrui Pharmaceutical Recent Development
11.9 Changzhou Siyao
11.9.1 Changzhou Siyao Corporation Information
11.9.2 Changzhou Siyao Description, Business Overview and Total Revenue
11.9.3 Changzhou Siyao Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
11.9.5 Changzhou Siyao Recent Development
11.10 Rfl Pharmaceutical
11.10.1 Rfl Pharmaceutical Corporation Information
11.10.2 Rfl Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Rfl Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
11.10.5 Rfl Pharmaceutical Recent Development
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
11.1.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.12 Purdue Pharma L.P.
11.12.1 Purdue Pharma L.P. Corporation Information
11.12.2 Purdue Pharma L.P. Description, Business Overview and Total Revenue
11.12.3 Purdue Pharma L.P. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Purdue Pharma L.P. Products Offered
11.12.5 Purdue Pharma L.P. Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.13.2 Teva Pharmaceutical Industries Ltd. Description, Business Overview and Total Revenue
11.13.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Pharmaceutical Industries Ltd. Products Offered
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Transdermal Skin Patch Market Estimates and Projections by Region
12.1.1 Global Transdermal Skin Patch Sales Forecast by Regions 2021-2026
12.1.2 Global Transdermal Skin Patch Revenue Forecast by Regions 2021-2026
12.2 North America Transdermal Skin Patch Market Size Forecast (2021-2026)
12.2.1 North America: Transdermal Skin Patch Sales Forecast (2021-2026)
12.2.2 North America: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.2.3 North America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.3 Europe Transdermal Skin Patch Market Size Forecast (2021-2026)
12.3.1 Europe: Transdermal Skin Patch Sales Forecast (2021-2026)
12.3.2 Europe: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.3.3 Europe: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transdermal Skin Patch Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transdermal Skin Patch Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transdermal Skin Patch Market Size Forecast by Region (2021-2026)
12.5 Latin America Transdermal Skin Patch Market Size Forecast (2021-2026)
12.5.1 Latin America: Transdermal Skin Patch Sales Forecast (2021-2026)
12.5.2 Latin America: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.5.3 Latin America: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transdermal Skin Patch Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transdermal Skin Patch Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transdermal Skin Patch Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transdermal Skin Patch Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transdermal Skin Patch Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Transdermal Skin Patch Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Transdermal Skin Patch Market Segments
Table 2. Ranking of Global Top Transdermal Skin Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Skin Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Fentanyl Transdermal Skin Patch
Table 5. Major Manufacturers of Nicotine Transdermal Skin Patch
Table 6. Major Manufacturers of Clonidine Transdermal Skin Patch
Table 7. Major Manufacturers of Buprenorphine Transdermal Skin Patch
Table 8. COVID-19 Impact Global Market: (Four Transdermal Skin Patch Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Transdermal Skin Patch Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact
Table 13. Global Transdermal Skin Patch Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Transdermal Skin Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Transdermal Skin Patch Sales by Regions 2015-2020 (K Units)
Table 16. Global Transdermal Skin Patch Sales Market Share by Regions (2015-2020)
Table 17. Global Transdermal Skin Patch Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Transdermal Skin Patch Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Transdermal Skin Patch Sales Share by Manufacturers (2015-2020)
Table 20. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patch as of 2019)
Table 22. Transdermal Skin Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Transdermal Skin Patch Price (2015-2020) (USD/Unit)
Table 25. Transdermal Skin Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Transdermal Skin Patch Product Type
Table 27. Date of International Manufacturers Enter into Transdermal Skin Patch Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 30. Global Transdermal Skin Patch Sales Share by Type (2015-2020)
Table 31. Global Transdermal Skin Patch Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Transdermal Skin Patch Revenue Share by Type (2015-2020)
Table 33. Transdermal Skin Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 35. Global Transdermal Skin Patch Sales Share by Application (2015-2020)
Table 36. North America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 37. North America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 38. North America Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 40. North America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 41. North America Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 42. North America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 43. North America Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 44. Europe Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 45. Europe Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 46. Europe Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 48. Europe Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 49. Europe Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 50. Europe Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 51. Europe Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Transdermal Skin Patch Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 60. Latin America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 61. Latin America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 64. Latin America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 65. Latin America Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 66. Latin America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 67. Latin America Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 76. Hisamitsu Pharmaceutical Corporation Information
Table 77. Hisamitsu Pharmaceutical Description and Major Businesses
Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Hisamitsu Pharmaceutical Product
Table 80. Hisamitsu Pharmaceutical Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Major Businesses
Table 88. Johnson & Johnson Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Recent Development
Table 91. Teikoku Pharma Corporation Information
Table 92. Teikoku Pharma Description and Major Businesses
Table 93. Teikoku Pharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Teikoku Pharma Product
Table 95. Teikoku Pharma Recent Development
Table 96. Mylan Corporation Information
Table 97. Mylan Description and Major Businesses
Table 98. Mylan Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Mylan Product
Table 100. Mylan Recent Development
Table 101. Actavis Corporation Information
Table 102. Actavis Description and Major Businesses
Table 103. Actavis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Actavis Product
Table 105. Actavis Recent Development
Table 106. Mundipharma Corporation Information
Table 107. Mundipharma Description and Major Businesses
Table 108. Mundipharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mundipharma Product
Table 110. Mundipharma Recent Development
Table 111. Henan Lingrui Pharmaceutical Corporation Information
Table 112. Henan Lingrui Pharmaceutical Description and Major Businesses
Table 113. Henan Lingrui Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Henan Lingrui Pharmaceutical Product
Table 115. Henan Lingrui Pharmaceutical Recent Development
Table 116. Changzhou Siyao Corporation Information
Table 117. Changzhou Siyao Description and Major Businesses
Table 118. Changzhou Siyao Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Changzhou Siyao Product
Table 120. Changzhou Siyao Recent Development
Table 121. Rfl Pharmaceutical Corporation Information
Table 122. Rfl Pharmaceutical Description and Major Businesses
Table 123. Rfl Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Rfl Pharmaceutical Product
Table 125. Rfl Pharmaceutical Recent Development
Table 126. Luye Pharma Group Ltd. Corporation Information
Table 127. Luye Pharma Group Ltd. Description and Major Businesses
Table 128. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Luye Pharma Group Ltd. Product
Table 130. Luye Pharma Group Ltd. Recent Development
Table 131. Purdue Pharma L.P. Corporation Information
Table 132. Purdue Pharma L.P. Description and Major Businesses
Table 133. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Purdue Pharma L.P. Product
Table 135. Purdue Pharma L.P. Recent Development
Table 136. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 137. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 138. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Teva Pharmaceutical Industries Ltd. Product
Table 140. Teva Pharmaceutical Industries Ltd. Recent Development
Table 141. Global Transdermal Skin Patch Sales Forecast by Regions (2021-2026) (K Units)
Table 142. Global Transdermal Skin Patch Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Transdermal Skin Patch Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Transdermal Skin Patch Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 146. North America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 148. Europe: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Transdermal Skin Patch Sales Forecast by Region (2021-2026) (K Units)
Table 150. Asia Pacific: Transdermal Skin Patch Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 152. Latin America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 154. Middle East and Africa: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Transdermal Skin Patch Players
Table 159. Transdermal Skin Patch Customers List
Table 160. Transdermal Skin Patch Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 1. Transdermal Skin Patch Market Segments
Table 2. Ranking of Global Top Transdermal Skin Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transdermal Skin Patch Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Fentanyl Transdermal Skin Patch
Table 5. Major Manufacturers of Nicotine Transdermal Skin Patch
Table 6. Major Manufacturers of Clonidine Transdermal Skin Patch
Table 7. Major Manufacturers of Buprenorphine Transdermal Skin Patch
Table 8. COVID-19 Impact Global Market: (Four Transdermal Skin Patch Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Transdermal Skin Patch Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Transdermal Skin Patch Players to Combat Covid-19 Impact
Table 13. Global Transdermal Skin Patch Market Size Growth Rate by Application 2020-2026 (K Units)
Table 14. Global Transdermal Skin Patch Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 15. Global Transdermal Skin Patch Sales by Regions 2015-2020 (K Units)
Table 16. Global Transdermal Skin Patch Sales Market Share by Regions (2015-2020)
Table 17. Global Transdermal Skin Patch Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Transdermal Skin Patch Sales by Manufacturers (2015-2020) (K Units)
Table 19. Global Transdermal Skin Patch Sales Share by Manufacturers (2015-2020)
Table 20. Global Transdermal Skin Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Skin Patch as of 2019)
Table 22. Transdermal Skin Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Transdermal Skin Patch Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Transdermal Skin Patch Price (2015-2020) (USD/Unit)
Table 25. Transdermal Skin Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Transdermal Skin Patch Product Type
Table 27. Date of International Manufacturers Enter into Transdermal Skin Patch Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 30. Global Transdermal Skin Patch Sales Share by Type (2015-2020)
Table 31. Global Transdermal Skin Patch Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Transdermal Skin Patch Revenue Share by Type (2015-2020)
Table 33. Transdermal Skin Patch Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 34. Global Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 35. Global Transdermal Skin Patch Sales Share by Application (2015-2020)
Table 36. North America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 37. North America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 38. North America Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 40. North America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 41. North America Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 42. North America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 43. North America Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 44. Europe Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 45. Europe Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 46. Europe Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 48. Europe Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 49. Europe Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 50. Europe Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 51. Europe Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Transdermal Skin Patch Sales by Region (2015-2020) (K Units)
Table 53. Asia Pacific Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Transdermal Skin Patch Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 57. Asia Pacific Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 59. Asia Pacific Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 60. Latin America Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 61. Latin America Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 64. Latin America Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 65. Latin America Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 66. Latin America Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 67. Latin America Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Transdermal Skin Patch Sales by Country (2015-2020) (K Units)
Table 69. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Transdermal Skin Patch Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Transdermal Skin Patch Sales by Type (2015-2020) (K Units)
Table 73. Middle East and Africa Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Transdermal Skin Patch Sales by Application (2015-2020) (K Units)
Table 75. Middle East and Africa Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Table 76. Hisamitsu Pharmaceutical Corporation Information
Table 77. Hisamitsu Pharmaceutical Description and Major Businesses
Table 78. Hisamitsu Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Hisamitsu Pharmaceutical Product
Table 80. Hisamitsu Pharmaceutical Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Major Businesses
Table 83. Novartis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Johnson & Johnson Corporation Information
Table 87. Johnson & Johnson Description and Major Businesses
Table 88. Johnson & Johnson Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Recent Development
Table 91. Teikoku Pharma Corporation Information
Table 92. Teikoku Pharma Description and Major Businesses
Table 93. Teikoku Pharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Teikoku Pharma Product
Table 95. Teikoku Pharma Recent Development
Table 96. Mylan Corporation Information
Table 97. Mylan Description and Major Businesses
Table 98. Mylan Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Mylan Product
Table 100. Mylan Recent Development
Table 101. Actavis Corporation Information
Table 102. Actavis Description and Major Businesses
Table 103. Actavis Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Actavis Product
Table 105. Actavis Recent Development
Table 106. Mundipharma Corporation Information
Table 107. Mundipharma Description and Major Businesses
Table 108. Mundipharma Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Mundipharma Product
Table 110. Mundipharma Recent Development
Table 111. Henan Lingrui Pharmaceutical Corporation Information
Table 112. Henan Lingrui Pharmaceutical Description and Major Businesses
Table 113. Henan Lingrui Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. Henan Lingrui Pharmaceutical Product
Table 115. Henan Lingrui Pharmaceutical Recent Development
Table 116. Changzhou Siyao Corporation Information
Table 117. Changzhou Siyao Description and Major Businesses
Table 118. Changzhou Siyao Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Changzhou Siyao Product
Table 120. Changzhou Siyao Recent Development
Table 121. Rfl Pharmaceutical Corporation Information
Table 122. Rfl Pharmaceutical Description and Major Businesses
Table 123. Rfl Pharmaceutical Transdermal Skin Patch Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Rfl Pharmaceutical Product
Table 125. Rfl Pharmaceutical Recent Development
Table 126. Luye Pharma Group Ltd. Corporation Information
Table 127. Luye Pharma Group Ltd. Description and Major Businesses
Table 128. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Luye Pharma Group Ltd. Product
Table 130. Luye Pharma Group Ltd. Recent Development
Table 131. Purdue Pharma L.P. Corporation Information
Table 132. Purdue Pharma L.P. Description and Major Businesses
Table 133. Purdue Pharma L.P. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Purdue Pharma L.P. Product
Table 135. Purdue Pharma L.P. Recent Development
Table 136. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 137. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 138. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Teva Pharmaceutical Industries Ltd. Product
Table 140. Teva Pharmaceutical Industries Ltd. Recent Development
Table 141. Global Transdermal Skin Patch Sales Forecast by Regions (2021-2026) (K Units)
Table 142. Global Transdermal Skin Patch Sales Market Share Forecast by Regions (2021-2026)
Table 143. Global Transdermal Skin Patch Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 144. Global Transdermal Skin Patch Revenue Market Share Forecast by Regions (2021-2026)
Table 145. North America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 146. North America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Europe: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 148. Europe: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Asia Pacific: Transdermal Skin Patch Sales Forecast by Region (2021-2026) (K Units)
Table 150. Asia Pacific: Transdermal Skin Patch Revenue Forecast by Region (2021-2026) (US$ Million)
Table 151. Latin America: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 152. Latin America: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Middle East and Africa: Transdermal Skin Patch Sales Forecast by Country (2021-2026) (K Units)
Table 154. Middle East and Africa: Transdermal Skin Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Transdermal Skin Patch Players
Table 159. Transdermal Skin Patch Customers List
Table 160. Transdermal Skin Patch Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Transdermal Skin Patch Product Picture
Figure 2. Global Transdermal Skin Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Fentanyl Transdermal Skin Patch Product Picture
Figure 4. Nicotine Transdermal Skin Patch Product Picture
Figure 5. Clonidine Transdermal Skin Patch Product Picture
Figure 6. Buprenorphine Transdermal Skin Patch Product Picture
Figure 7. Global Transdermal Skin Patch Sales Market Share by Application in 2020 & 2026
Figure 8. Relieve Severe Pain
Figure 9. Stop Smoking Cigarettes
Figure 10. Treat An Overactive Bladder
Figure 11. Others
Figure 12. Transdermal Skin Patch Report Years Considered
Figure 13. Global Transdermal Skin Patch Market Size 2015-2026 (US$ Million)
Figure 14. Global Transdermal Skin Patch Sales 2015-2026 (K Units)
Figure 15. Global Transdermal Skin Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Figure 17. Global Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Figure 19. Global Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 20. Global Transdermal Skin Patch Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2019
Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Figure 24. Global Transdermal Skin Patch Sales Market Share by Type in 2019
Figure 25. Global Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
Figure 26. Global Transdermal Skin Patch Revenue Market Share by Type in 2019
Figure 27. Global Transdermal Skin Patch Market Share by Price Range (2015-2020)
Figure 28. Global Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Figure 29. Global Transdermal Skin Patch Sales Market Share by Application in 2019
Figure 30. Global Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
Figure 31. Global Transdermal Skin Patch Revenue Market Share by Application in 2019
Figure 32. North America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 35. North America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 36. U.S. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Transdermal Skin Patch Market Share by Type in 2019
Figure 41. North America Transdermal Skin Patch Market Share by Application in 2019
Figure 42. Europe Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 45. Europe Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 46. Germany Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Transdermal Skin Patch Market Share by Type in 2019
Figure 57. Europe Transdermal Skin Patch Market Share by Application in 2019
Figure 58. Asia Pacific Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 61. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 62. China Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Transdermal Skin Patch Market Share by Type in 2019
Figure 85. Asia Pacific Transdermal Skin Patch Market Share by Application in 2019
Figure 86. Latin America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 89. Latin America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 90. Mexico Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Transdermal Skin Patch Market Share by Type in 2019
Figure 97. Latin America Transdermal Skin Patch Market Share by Application in 2019
Figure 98. Middle East and Africa Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 102. Turkey Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Transdermal Skin Patch Market Share by Type in 2019
Figure 109. Middle East and Africa Transdermal Skin Patch Market Share by Application in 2019
Figure 110. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Henan Lingrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Changzhou Siyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Rfl Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Luye Pharma Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Purdue Pharma L.P. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. North America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Europe Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Asia Pacific Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Latin America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
Figure 1. Transdermal Skin Patch Product Picture
Figure 2. Global Transdermal Skin Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Fentanyl Transdermal Skin Patch Product Picture
Figure 4. Nicotine Transdermal Skin Patch Product Picture
Figure 5. Clonidine Transdermal Skin Patch Product Picture
Figure 6. Buprenorphine Transdermal Skin Patch Product Picture
Figure 7. Global Transdermal Skin Patch Sales Market Share by Application in 2020 & 2026
Figure 8. Relieve Severe Pain
Figure 9. Stop Smoking Cigarettes
Figure 10. Treat An Overactive Bladder
Figure 11. Others
Figure 12. Transdermal Skin Patch Report Years Considered
Figure 13. Global Transdermal Skin Patch Market Size 2015-2026 (US$ Million)
Figure 14. Global Transdermal Skin Patch Sales 2015-2026 (K Units)
Figure 15. Global Transdermal Skin Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Transdermal Skin Patch Sales Market Share by Region (2015-2020)
Figure 17. Global Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 18. Global Transdermal Skin Patch Revenue Market Share by Region (2015-2020)
Figure 19. Global Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 20. Global Transdermal Skin Patch Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Transdermal Skin Patch Revenue in 2019
Figure 22. Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Transdermal Skin Patch Sales Market Share by Type (2015-2020)
Figure 24. Global Transdermal Skin Patch Sales Market Share by Type in 2019
Figure 25. Global Transdermal Skin Patch Revenue Market Share by Type (2015-2020)
Figure 26. Global Transdermal Skin Patch Revenue Market Share by Type in 2019
Figure 27. Global Transdermal Skin Patch Market Share by Price Range (2015-2020)
Figure 28. Global Transdermal Skin Patch Sales Market Share by Application (2015-2020)
Figure 29. Global Transdermal Skin Patch Sales Market Share by Application in 2019
Figure 30. Global Transdermal Skin Patch Revenue Market Share by Application (2015-2020)
Figure 31. Global Transdermal Skin Patch Revenue Market Share by Application in 2019
Figure 32. North America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 35. North America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 36. U.S. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Transdermal Skin Patch Market Share by Type in 2019
Figure 41. North America Transdermal Skin Patch Market Share by Application in 2019
Figure 42. Europe Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 45. Europe Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 46. Germany Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Transdermal Skin Patch Market Share by Type in 2019
Figure 57. Europe Transdermal Skin Patch Market Share by Application in 2019
Figure 58. Asia Pacific Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Transdermal Skin Patch Sales Market Share by Region in 2019
Figure 61. Asia Pacific Transdermal Skin Patch Revenue Market Share by Region in 2019
Figure 62. China Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Transdermal Skin Patch Market Share by Type in 2019
Figure 85. Asia Pacific Transdermal Skin Patch Market Share by Application in 2019
Figure 86. Latin America Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 89. Latin America Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 90. Mexico Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Transdermal Skin Patch Market Share by Type in 2019
Figure 97. Latin America Transdermal Skin Patch Market Share by Application in 2019
Figure 98. Middle East and Africa Transdermal Skin Patch Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Transdermal Skin Patch Revenue Market Share by Country in 2019
Figure 102. Turkey Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Transdermal Skin Patch Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Transdermal Skin Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Transdermal Skin Patch Market Share by Type in 2019
Figure 109. Middle East and Africa Transdermal Skin Patch Market Share by Application in 2019
Figure 110. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Teikoku Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Actavis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Henan Lingrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Changzhou Siyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Rfl Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Luye Pharma Group Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Purdue Pharma L.P. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Teva Pharmaceutical Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. North America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. North America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Europe Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Europe Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Asia Pacific Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 128. Asia Pacific Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Latin America Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 130. Latin America Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Middle East and Africa Transdermal Skin Patch Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 132. Middle East and Africa Transdermal Skin Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Porter's Five Forces Analysis
Figure 134. Channels of Distribution
Figure 135. Distributors Profiles
Figure 136. Bottom-up and Top-down Approaches for This Report
Figure 137. Data Triangulation
Figure 138. Key Executives Interviewed
